How do we know where we are, where we have been and where we are going? Such are the questions that the Kavli Institute for Systems Neuroscience at the Norwegian University of Science and Technology (NTNU) in Trondheim aims to answer. The Institute seeks to unlock the secrets of memory by studying the neural microcircuits and networks in the hippocampus and associated areas of the brain, where memory is encoded, stored and retrieved. It focuses in particular on the memory of place and direction that underlies our spatial navigation skills.
Conducting basic and translational research within the areas of synaptic transmission and plasticity in the neurosystem
The Neuroscience Research Group consists of six principle investigators conducting basic and translational research within the areas of synaptic transmission and plasticity in the hippocampus, memory mechanisms and hippocampal function, neural mechanisms related to regulation and transmission of pain, synaptic and cellular mechanisms of visual processing, sleep mechanisms, cognitive function and depression, and applied image analysis and neuroinformatics.
Headquartered in Israel, Teva operates in 60 countries and has 46,000 employees worldwide. The company was established in Jerusalem in 1901, and is today a global generic pharmaceuticals leader and one of the top 15 pharmaceutical companies in the world.
Tevais aleader inthe treatment of multiplesclerosis (MS). The company marketsdrugs thatcanmodify thedisease courseof MS, and is currently developing new drugs in this field. Teva also has asubstantial investmentin a range ofother therapeuticareas, including Parkinson’s disease and Attention Deficit/Hyperactivity Disorder (ADHD).
Supported by Innovation Norway. Copyright © 2012 NansenNeuroScience. All Rights Reserved. Web support: Sustainovate